32 Carpenter Street
AI in Digital Health Past, Present and Future
Presented by General Assembly. Partnered with SGInnovate
In health care, AI and related technologies (like machine learning) can be used to gain insight into a patient’s medical history, present state, and potential future outcomes. Healthcare companies supporting patients or providers will leverage AI to provide specific, personalized insights based on an individual’s current health status, lifestyle, behavior, and genetic information. Join our panel of experts for an evening exploring how data, AI and technology are redesigning healthcare.
Date : 27 August 2018
Time : 7:00pm – 9:00pm
Venue : 32 Carpenter Street, Singapore 059911
6:30pm - 7:00pm: Check-in & Networking
7:00pm - 7:45pm: Panel/Lighting Talks
7:45pm - 8:15pm: Q&A
8:15pm - 9:00pm: Networking
- Dr Yau Teng Yan (MBBS, MMed, FRCR), Chief Medical Officer, Holmusk
- Joey Chao, VP of Product, MyDoc
- Julien de Salaberry, CEO & Founder, Galen Growth Asia: The Asia HealthTech Builder
Dr Yau Teng Yan (MBBS, MMed, FRCR)
Chief Medical Officer, Holmusk
Dr Yau Teng Yan (MBBS, M.Med, FRCR) is Chief Medical Officer at Holmusk, a healthcare company that leverages technology and data science to deliver effective, engaging and scalable digital programmes for people living with chronic diseases like diabetes. His current work also includes a grant from the Ministry of Health on a technology-driven intervention programme for dementia prevention, and with the Health Promotion Board on a digital health coaching intervention for overweight & obese children.
Prior to Holmusk, Teng Yan was a practicing doctor for 7 years in several public hospitals in Singapore including Tan Tock Seng Hospital and Singapore General Hospital. He trained in diagnostic radiology and is a fellow of the Royal College of Radiologists (London). He has also worked at the Military Medicine Institute where he was involved in health policy decisions and health screening initiatives in the Singapore Armed Forces.
He is a big believer that technology and artificial intelligence will transform the delivery of healthcare, to achieve better outcomes, reduced costs and improved patient experience.
VP of Product, MyDoc
Joey Chao oversees product management at MyDoc. He is a business technologist who has worked with various B2B and B2C technology companies from Silicon Valley to China to Southeast Asia.
Prior to MyDoc, he was based in Bangkok and Singapore, where he was responsible for product management for the China market at Agoda, a global online accommodation reservations provider, part of Booking Holdings. In China, he ran his own startup in international education and technology and also opened the development center for SugarCRM, a customer relationship management company based in Cupertino, California.
Before moving to Asia in 2008, Joey had several roles in the enterprise software industry in the San Francisco Bay Area. He holds a Bachelor of Science from Stanford University in Computer Systems Engineering.
Julien de Salaberry
CEO & Founder, Galen Growth Asia: The Asia HealthTech Builder
Changing the world comes in many forms - I am a healthcare change catalyst and evangelist who challenges the status quo in healthcare whilst understanding the world in which healthcare providers and organizations function. I strongly believe that medicine and healthcare are being transformed driven by Deep Tech representing an unprecedented opportunity for better patient outcome in Asia. I am the Founder and CEO of Galen Growth Asia, whose mission it is to build a sustainable and vibrant HealthTech ecosystem across Asia by scaling digital health innovation through industry partnerships.
With over 15 years of experience in healthcare with leading brands including Eli Lilly, Boston Scientific, Baxter, GSK, Merck&Co., I have a deep understanding of organic and inorganic growth in healthcare in both developed and emerging markets. I gained extensive international business experience across Europe, Middle East and Asia.
In 2012, I founded The Propell Group, a boutique venture investor and advisory firm, based in Singapore, which focuses on HealthTech startups and growth companies.
I also co-founded the Global Cancer Research & Commercialisation Fund in 2016 to establish greater collaboration and open innovation between research institutes, research foundations and investors from all corners of the globe. The fund’s goal is to harness technology and business model innovation to deliver superior financial returns and, most importantly, drive better outcomes for cancer patients.
I co-wrote iDisrupted (published in November 2014) which focused on creating an understanding of the IR4's significant technological changes which are just beginning to re-shape our daily lives. I am now co-writing its sequel where we will address how IR4 is changing society.
I am also a regular speaker on HealthTech / Digital Health Innovation and Disruption.
You may also like the following:
Quantum Tech: From Science to Business Applications
How is quantum technology going to change our daily life? Can quantum computers predict our future? What are the possible business applications and how do we prepare for them starting today? We’ll take a deep look into technology – moving from theory to practical implementationTopics:
What Can We Expect from Machine Cognition
Recent decades have witnessed the remarkable progress in artificial intelligence (AI). However, there are still opposing views on the prospect of AI as being yet another cyclic hype or a new development with sustaining power. As the evidence becomes less controversial in the area of recognition, we focus the discussion on the next level of mental capacity necessary to intelligent behaviors, namely, the capability of cognition that involves knowledge acquisition, inference and reasoning, and reinforcement learning. We present our views by way of the current status of Microsoft Academic Graph (MAG), a project in Microsoft Research that teaches machine to obtain knowledge by reading scholarly publications, and contemplate what machine can do in the near future based on the trajectory being observed thus far. As MAG is open to the public, how it can be used through PySpark and what types of applications it has enabled will also be described.Topics:
Appier Masterclass: Creativity in AI
At the second Appier AI Masterclass, Dr Min Sun, Chief AI Scientist at Appier, will discuss the current capabilities and future potential of Artificial Intelligence to generate creative outputs. Dr Sun will share the research trends in this direction and what his extensive research has uncovered. Finally, he will show how he applies this knowledge at Appier, and how to effectively use AI and deep learning in the creative process.Topics:
Future Economy: AI and the Future of Work
The future of work is increasingly becoming a reality with Artificial Intelligence (AI) set to deliver step changes in productivity last witnessed with mass production in the 1920s – only this time across multiple industries and sectors.Topics:
Jump-start Alumni Gathering
Calling all our Jump-start alumni as we come together to explore and talk about the current state-of-the-art technologies in Deep Learning. Building upon the foundational knowledge in module one, Dr Martin and Sam will teach and touch on advanced deep learning in Computer Vision and advanced Natural Language Processing, Text and Sequences.Topics: